Xanadu Quantum Technologies Ltd current report, Q2 FY2026

Business Context and Reporting Period

This Form 6-K filing by Xanadu Quantum Technologies Limited covers the month of May 2026. The report details the entry into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. ("Yorkville") on May 20, 2026, establishing a synthetic at-the-market equity program.

Key Financial Metrics and Capital Structure

  • Commitment Amount: Up to $300,000,000 in Subordinate Voting Shares.
  • Purchase Price: 97.50% of the Market Price (volume-weighted average price on the principal U.S. market), subject to a TSX Minimum Price floor.
  • Ownership Limitation: Yorkville cannot purchase shares that would result in beneficial ownership exceeding 4.99% of outstanding voting power.
  • Commitment Fee: 0.45% of the aggregate commitment amount ($1,350,000), fully earned upon execution. The Company elected to pay this via deductions from gross proceeds of future advances.
  • Structuring Fee: $25,000 paid upon execution.
  • Term: 36 months from the Effective Date or until the full $300 million commitment is utilized, whichever occurs first.
  • Use of Proceeds: Working capital and general corporate purposes.

Note: The filing does not provide specific revenue, profit, cash flow, or existing debt figures for the reporting period.

Material Changes

The primary material change is the establishment of the $300 million equity facility. This provides the Company with the option, but not the obligation, to sell shares to Yorkville at its discretion. There is no mandatory minimum amount for any single sale ("Advance") and no non-usage fee for failing to utilize the full commitment.

Outlook, Risks, and Management Commentary

Management intends to use the program to strategically and prudently tap the equity market to fund its growth strategy and long-term roadmap toward fault-tolerant quantum computing. The Company expects to file a registration statement with the SEC to register the resale of shares by Yorkville.

Risks and Contingencies:

  • Dilution: Issuance of shares will dilute the economic and voting interests of existing shareholders.
  • Share Price Impact: Sales under the agreement or the perception of potential sales could cause the share price to decline.
  • Operational Risks: The Company faces significant technical challenges in commercializing emerging quantum technology, has a history of net losses, and relies on government contracts.
  • Forward-Looking Statements: Actual results may differ materially from projections due to market conditions, regulatory changes, and the ability to attract talent.

Investor Verification Checklist

  • Verify the effectiveness of the SEC registration statement required for Yorkville's resale of shares.
  • Monitor the Company's utilization of the $300 million facility and the resulting dilution to existing shareholders.
  • Review the Company's cash burn rate and working capital needs to assess the likelihood of immediate sales under the agreement.
  • Confirm the current trading price relative to the TSX Minimum Price to understand the potential discount on future issuances.
  • Assess the Company's progress on its quantum computing roadmap and commercialization milestones given the reliance on future financing.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.